The Current Ratio as of June 2026 (TTM) for enGene Holdings Inc. (ENGN) is 11.75

According to enGene Holdings Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 11.75. This represents a change of 14.51% compared to the average of 10.26 of the last 4 quarters.

enGene Holdings Inc. (ENGN) Historical Current Ratio (quarterly & annually)

How has ENGN Current Ratio performed in the past?

The mean historical Current Ratio of enGene Holdings Inc. over the last ten years is 7.46. The current 11.75 Current Ratio has changed 15.65% with respect to the historical average. Over the past ten years (40 quarters), ENGN's Current Ratio was at its highest in in the April 2024 quarter at 42.80. The Current Ratio was at its lowest in in the July 2023 quarter at 0.04.

enGene Holdings Inc. (ENGN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of enGene Holdings Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

enGene Holdings Inc. (ENGN) Average Current Ratio

How has ENGN Current Ratio performed in the past?

The current Current Ratio of enGene Holdings Inc. (ENGN) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

enGene Holdings Inc. (ENGN) Current Ratio vs. Peers

How is ENGN’s Current Ratio compared to its peers?

enGene Holdings Inc.’s Current Ratio is greater than Amarin Corporation plc (3.48), less than Altimmune, Inc. (29.56), greater than Korro Bio, Inc. (8.13), greater than DBV Technologies S.A. (4.76), greater than Larimar Therapeutics, Inc. (4.29), greater than Cellectis S.A. (1.52), greater than Annexon, Inc. (6.35), less than Alto Neuroscience, Inc. (20.52), greater than AC Immune S.A. (0.87), greater than Silence Therapeutics plc (9.83),

Build a custom stock screener for enGene Holdings Inc. (ENGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like enGene Holdings Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

enGene Holdings Inc. (ENGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like enGene Holdings Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.